top of page
Abstract Structure

Transaction and News

Eucure Biopharma, a Subsidiary of Biocytogen Pharmaceuticals, Licenses OX40 Antibody (YH002) and Multiple Active Ingredients to Syncromune for the Development and Commercialization of Intratumoral Immunotherapy

October 18, 2022 at 9:33:05 AM

Volkswagen Acquiring Majority Stake In China’s Horizon Robotics For $2.35 Billion

October 16, 2022 at 8:39:53 AM

IASO Biotherapeutics and Cabaletta Bio Announce Exclusive Worldwide License Agreement

October 12, 2022 at 8:03:30 AM

China's Geely Buys Into U.K. Sports Car Maker Aston Martin

October 8, 2022 at 9:07:07 AM

Advent Acquires Majority Interest in Chinese Restaurant Operator Wagas

September 22, 2022 at 8:03:19 AM

BorgWarner to Acquire Charging Business of Hubei Surpass Sun Electric

September 21, 2022 at 8:08:35 AM

Abstract Structure
Collabrium Partners Logo

Company

Business

Legal

Location

Collabrium Partners & Co. Limited

9/F, Surson Commercial Building
140-142 Austin Road,
Tsim Sha Tsui, Kowloon,
Hong Kong

© 2019 Collabrium Partners & Co. Limited all rights reserved.

Mergers & Acquisitions
Strategic Advisory
Capital Restructuring
Private Placement
Special Committee
Independent Advice
Privacy Policy
Other Notices
Hong Kong
Beijing
Shanghai
Shenzhen
New York
London
Dubai
bottom of page